Held at the Brisbane Convention & Exhibition Centre, 5-6 November 2021, the conference will focus on the diagnosis and management of skin cancers, in particular basal and squamous cell carcinomas. It will address new methods to identify cancer risk in individuals, methods for prevention, new therapies for advanced and resistant forms of disease, and the cancer behavior in specific populations arming clinicians, consumers, and industry representatives with the knowledge required to improve patient outcomes.
We are excited to focus the program around problem centered multidisciplinary sessions, covering a range of clinical issues faced in treating and preventing skin cancers.
Submit your abstract
Abstracts (written) are to outline your 3-minute video presentation. Abstracts will be considered by the selection committee for the 3-minute video presentation, available on demand. Best abstracts will be selected for an additional 1-minute in-person presentation only available to those attending on the day.
Please note the following key dates:
Speaker abstracts open 1 May
Speaker abstracts close 28 June
Review complete 26 July
Selected speakers notified 2 August
All speakers must register 14 September
What works to stop people getting skin cancer?
How to best treat the field of sun-damage and does it prevent skin cancer?
Does technology improve diagnosis and detection of skin cancers?
What options are available for advanced disease? New developments in neoadjuvant and immune-based therapies: implications for patient care
What’s new in genetics, and what does it mean for patients?
How should we manage organ transplant recipients?
New developments in managing perineural invasion
Rare Cancers of the Skin
Updates on Merkel Cell Carcinomas and other lethal lesions